Prosus Invests $460 million in French health tech Alan

Dutch investment company Prosus has invested $460 million into French health tech company Alan, valuing the startup at $6.3 billion, the company ‌said ⁠on Wednesday.

Alan operates ⁠in France, Canada, ​Belgium and Spain and offers services such as ​health insurance and telehealth. The company has an ​annual recurring revenue ⁠of 800 ‌million euros ($909.04 ​million) ​as of the first ⁠quarter of 2026.

* The investment ​will consist of both ​primary and secondary equity


* It will help drive Alan's expansion in international markets and accelerate its ‌AI-led product development

* Prosus will also provide ​Alan ​with access ⁠to its Large Commerce Model

* The transaction's closing is subject to ​applicable regulatory approvals, including from French financial authorities

($1 = 0.8800 euros)